TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Metastatic Cancer Drugs Market – By Cancer Type
1.3.2 North America Metastatic Cancer Drugs Market – By Route of Administration
1.3.3 North America Metastatic Cancer Drugs Market – By Drug Class
1.3.4 North America Metastatic Cancer Drugs Market – By Product
1.3.5 North America Metastatic Cancer Drugs Market – By End User
1.3.6 North America Metastatic Cancer Drugs Market – By Country
2. North America Metastatic Cancer Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Metastatic Cancer Drugs Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.3 Expert Opinion
5. North America Metastatic Cancer Drugs Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Metastatic Cancer
5.1.2 Government Initiatives to Support Developments in Cancer Treatment
5.2 Market Restraints
5.2.1 High Cost of Oncology Drugs
5.3 Market Opportunities
5.3.1 Investments in Artificial Intelligence for Oncology Drug Development
5.4 Future Trends
5.4.1 Increase in Launch of Metastatic Cancer Drugs
5.5 Impact analysis
6. North America Metastatic Cancer Drugs Market – Country Analysis
6.1 North America Metastatic Cancer Drugs Market Revenue Forecast and Analysis
7. North America Metastatic Cancer Drug Market Analysis – By Cancer Type
7.1 Overview
7.2 North America Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)
7.2.1 North America: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
7.3 Breast Cancer
7.3.1 Overview
7.3.2 Breast Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lung Cancer
7.4.1 Overview
7.4.2 Lung Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Liver Cancer
7.5.1 Overview
7.5.2 Liver Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Hematological Cancer
7.6.1 Overview
7.6.2 Hematological Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Brain Cancer
7.7.1 Overview
7.7.2 Brain Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Prostate Cancer
7.8.1 Overview
7.8.2 Prostate Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Pancreatic Cancer
7.9.1 Overview
7.9.2 Pancreatic Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Metastatic Cancer Drug Market – By Route of Administration
8.1 Overview
8.2 North America Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)
8.2.1 North America: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
8.3 Intravenous
8.3.1 Overview
8.3.2 Intravenous: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Intramuscular
8.4.1 Overview
8.4.2 Intramuscular: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Metastatic Cancer Drug Market – By Drug Class
9.1 Overview
9.2 North America Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)
9.2.1 North America: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
9.3 HER2 Inhibitors
9.3.1 Overview
9.3.2 HER2 Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Immune Checkpoints Inhibitors
9.4.1 Overview
9.4.2 Immune Checkpoints Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.5 PARP Inhibitors
9.5.1 Overview
9.5.2 PARP Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Kinase Inhibitors
9.6.1 Overview
9.6.2 Kinase Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Metastatic Cancer Drug Market – By Product
10.1 Overview
10.2 North America Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)
10.2.1 North America: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.3 Branded
10.3.1 Overview
10.3.2 Branded: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Generics and Biosimilars
10.4.1 Overview
10.4.2 Generics and Biosimilars: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Metastatic Cancer Drug Market – By End User
11.1 Overview
11.2 North America Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)
11.2.1 North America: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.3 Hospital
11.3.1 Overview
11.3.2 Hospitals: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.4 Specialty Clinic
11.4.1 Overview
11.4.2 Specialty Clinics: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
12. North America Metastatic Cancer Drugs Market – Regional Analysis
12.1 North America Metastatic Cancer Drugs Market Revenue Forecast and Analysis
12.1.1 North America Metastatic Cancer Drugs Market Revenue Forecast and Analysis
12.1.1.1 US: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.1 US: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.2 US: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.3 US: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.4 US: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.5 US: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
12.1.1.1.6 US: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
12.1.1.2 Canada: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.1 Canada: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.2 Canada: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.3 Canada: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.4 Canada: North America Metastatic Cancer Drug Market, by Drug Class– Revenue and Forecast to 2028 (USD Million)
12.1.1.2.5 Canada: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
12.1.1.2.6 Canada: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
12.1.1.3 Mexico: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.1 Mexico: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.2 Mexico: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.3 Mexico: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.4 Mexico: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
12.1.1.3.5 Mexico: North America Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)
12.1.1.3.6 Mexico: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
13. North America Metastatic Cancer Drug Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies in the North America Metastatic Cancer Drug Market, 2021-2028
13.3 Inorganic Developments
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 AbbVie Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Amgen Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. HOFFMANN-LA ROCHE LTD.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Astrazeneca
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Eli Lilly and Company.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MERCK KGaA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Pfizer Inc. (Arena Pharmaceutical GmbH)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Johnson and Johnson Services, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America: North America Metastatic Cancer Drug Market, – Revenue and Forecast to 2028 (USD Million)
Table 2. North America: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. North America: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5. North America: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. North America: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. US: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. US: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. US: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 10. US: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 11. US: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: North America Metastatic Cancer Drug Market, by Cancer Type - Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: North America Metastatic Cancer Drug Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: North America Metastatic Cancer Drug Market, by Drug Class - Revenue and Forecast to 2028 (USD Million)
Table 15. Canada: North America Metastatic Cancer Drug Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 16. Canada: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: North America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: North America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: North America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico: North America Metastatic Cancer Drug Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 21. Mexico: North America Metastatic Cancer Drug Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Recent Inorganic Growth Strategies in the North America Metastatic Cancer Drug Market
Table 23. Recent Organic Growth Strategies in the North America Metastatic Cancer Drug Market
Table 24. Glossary of Terms, North America Metastatic Cancer Drugs Market
LIST OF FIGURES.
Figure 1. North America Metastatic Cancer Drugs Market Segmentation
Figure 2. North America Metastatic Cancer Drugs Market Overview
Figure 3. The PARP Inhibitors Segment Held The Largest Share of Drug Class Segment in North America Metastatic Cancer Drugs Market
Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America PEST Analysis
Figure 6. Expert Opinion
Figure 7. North America Metastatic Cancer Drugs Market Impact Analysis of Driver and Restraints
Figure 8. North America Metastatic Cancer Drugs Market – Revenue Forecast and Analysis – 2021- 2028
Figure 9. North America Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)
Figure 10. Breast Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Lung Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Liver Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematological Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Brain Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Prostate Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Pancreatic Cancer: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)
Figure 19. Intravenous: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Intramuscular: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Oral: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)
Figure 24. HER2 Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Immune Checkpoints Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. PARP Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Kinase Inhibitors: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)
Figure 30. Branded: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Generics and Biosimilars: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)
Figure 33. Hospitals: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Specialty Clinics: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Others: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America Metastatic Cancer Drugs Market – By Country Forecast and Analysis – 2021- 2028.
Figure 37. North America: North America Metastatic Cancer Drug Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. US: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Canada: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Mexico: North America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Growth Strategies in the North America Metastatic Cancer Drug Market, 2021-2028